The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
CHITOSAN-GLYCEROL PHOSPHATE/BLOOD IMPLANTS IMPROVE HYALINE CARTILAGE REPAIR IN OVINE MICROFRACTURE DEFECTS
Abstract
BACKGROUND: Microfracture is a surgical procedure that is used to treat focal articular cartilage defects. Although joint function improves following microfracture, the procedure elicits incomplete repair. As blood clot formation in the microfracture defect is an essential initiating event in microfracture therapy, we hypothesized that the repair would be improved if the microfracture defect were filled with a blood clot that was stabilized by the incorporation of a thrombogenic and adhesive polymer, specifically, chitosan. The objectives of the present study were to evaluate (1) blood clot adhesion in fresh microfracture defects and (2) the quality of the repair, at six months postoperatively, of microfracture defects that had been treated with or without chitosan-glycerol phosphate/blood clot implants, using a sheep model. METHODS: In eighteen sheep, two 1-cm2 full-thickness chondral defects were created in the distal part of the femur and treated with microfracture; one defect was made in the medial femoral condyle, and the other defect was made in the trochlea. In four sheep, microfracture defects were created bilaterally; the microfracture defects in one knee received no further treatment, and the microfracture defects in the contralateral knee were filled with chitosan-glycerol phosphate/autologous whole blood and the implants were allowed to solidify. Fresh defects in these four sheep were collected at one hour postoperatively to compare the retention of the chitosan-glycerol phosphate/blood clot with that of the normal clot and to define the histologic characteristics of these fresh defects. In the other fourteen sheep, microfracture defects were made in only one knee and either were left untreated (control group; six sheep) or were treated with chitosan-glycerol phosphate/blood implant (treatment group; eight sheep), and the quality of repair was assessed histologically, histomorphometrically, and biochemically at six months postoperatively. RESULTS: In the defects that were examined one hour postoperatively, chitosan-glycerol phosphate/blood clots showed increased adhesion to the walls of the defects as compared with the blood clots in the untreated microfracture defects. After histological processing, all blood clots in the control microfracture defects had been lost, whereas chitosanglycerol phosphate/blood clot adhered to and was partly retained on the surfaces of the defect. At six months, defects that had been treated with chitosan-glycerol phosphate/blood were filled with significantly more hyaline repair tissue (p < 0.05) compared with control defects. Repair tissue from medial femoral condyle defects that had been treated with chitosan-glycerol phosphate/blood contained more cells and more collagen compared with control defects and showed complete restoration of glycosaminoglycan levels. CONCLUSIONS: Solidification of a chitosan-glycerol phosphate/blood implant in microfracture defects improved cartilage repair compared with microfracture alone by increasing the amount of tissue and improving its biochemical composition and cellular organization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Novel injectable neutral solutions of chitosan form biodegradable gels in situ
Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M. D., Hoemann, C. D., Leroux, J. C., Atkinson, B. L., Binette, F., & Selmani, A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00116-2 · Cited by 1,406
Self-citationFluorometric assay of DNA in cartilage explants using Hoechst 33258
Kim, Y.-J., Sah, R. L. Y., Doong, J.-Y. H., & Grodzinsky, A. J. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90532-5 · Cited by 1,357
Cell origin and differentiation in the repair of full-thickness defects of articular cartilage.
Shapiro, F., Koide, S., & Glimcher, M. J. (1993) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199304000-00009 · Cited by 1,253
Autologous Chondrocyte Implantation Compared with Microfracture in the Knee: A Randomized Trial
Knutsen, G., Engebretsen, L., Ludvigsen, T. C., Drogset, J. O., Grøntvedt, T., Solheim, E., Strand, T., Roberts, S., Isaksen, V., & Johansen, O. (2004) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-200403000-00001 · Cited by 1,248
The response of articular cartilage to mechanical injury.
Mankin, H. J. (1982) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-198264030-00022 · Cited by 1,223
Outcomes of microfracture for traumatic chondral defects of the knee: Average 11-year follow-up
Steadman, J. R., Briggs, K. K., Rodrigo, J. J., Kocher, M. S., Gill, T. J., & Rodkey, W. G. (2003) · Arthroscopy: The Journal of Arthroscopic & Related Surgery · doi:10.1053/jars.2003.50112 · Cited by 1,214
Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential
Rao, S. B., & Sharma, C. P. (1997) · Journal of Biomedical Materials Research · doi:10.1002/(sici)1097-4636(199701)34:1<21::aid-jbm4>3.0.co;2-p · Cited by 767
Evaluation of the biocompatibility of a chitosan scaffold in mice
VandeVord, P. J., Matthew, H. W. T., DeSilva, S. P., Mayton, L., Wu, B., & Wooley, P. H. (2002) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1270 · Cited by 747
A validated 1H NMR method for the determination of the degree of deacetylation of chitosan
Lavertu, M., Xia, Z., Serreqi, A. N., Berrada, M., Rodrigues, A., Wang, D., Buschmann, M. D., & Gupta, A. (2003) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(03)00155-9 · Cited by 691
Self-citationVenn, M., & Maroudas, A. (1977) · Annals of the Rheumatic Diseases · doi:10.1136/ard.36.2.121 · Cited by 572
Cited by
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Chitosan and its derivatives for tissue engineering applications
Kim, I.-Y., Seo, S.-J., Moon, H.-S., Yoo, M.-K., Park, I.-Y., Kim, B.-C., & Cho, C.-S. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.07.009 · Cited by 1,433
Chitosan as an environment friendly biomaterial – a review on recent modifications and applications
Bakshi, P. S., Selvakumar, D., Kadirvelu, K., & Kumar, N. S. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.10.113 · Cited by 1,016
Mithoefer, K., McAdams, T., Williams, R. J., Kreuz, P. C., & Mandelbaum, B. R. (2009) · The American Journal of Sports Medicine · doi:10.1177/0363546508328414 · Cited by 1,013
Chitosan Modification and Pharmaceutical/Biomedical Applications
Zhang, J., Xia, W., Liu, P., Cheng, Q., Tahi, T., Gu, W., & Li, B. (2010) · Marine Drugs · doi:10.3390/md8071962 · Cited by 526
Metadata
- Authors
- HOEMANN, C. D., HURTIG, M., ROSSOMACHA, E., SUN, J., CHEVRIER, A., SHIVE, M. S., & BUSCHMANN, M. D.
- Venue
- The Journal of Bone and Joint Surgery-American Volume
- Published
- 2005-12
- Volume
- 87
- Issue
- 12
- Pages
- 2671-2686
- ISSN
- 0021-9355 (ISSN-L)
- OpenAlex
- W2133529034
- Cited by
- 306
- References
- 31
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CHITOSAN-GLYCEROL PHOSPHATE/BLOOD IMPLANTS IMPROVE HYALINE CARTILAGE REPAIR IN OVINE MICROFRACTURE DEFECTS. https://app.cochat.ai/papers/10.2106/00004623-200512000-00011
- The paper
- HOEMANN, C. D., HURTIG, M., ROSSOMACHA, E., SUN, J., CHEVRIER, A., SHIVE, M. S., & BUSCHMANN, M. D. (2005). CHITOSAN-GLYCEROL PHOSPHATE/BLOOD IMPLANTS IMPROVE HYALINE CARTILAGE REPAIR IN OVINE MICROFRACTURE DEFECTS. The Journal of Bone and Joint Surgery-American Volume. https://doi.org/10.2106/00004623-200512000-00011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.